Literature DB >> 29276561

Jaw Dystonia and Reversible Basal Ganglia Changes as an Initial Presentation of Systemic Lupus Erythematosus.

Meghan Romba1, Yujie Wang1, Shu-Ching Hu1, Sandeep Khot1.   

Abstract

Dystonia as a manifestation of neuropsychiatric lupus erythematosus (NPSLE) is uncommon. We report a 25-year-old woman who experienced progressive confusion, reduced speech, and difficulty opening her mouth approximately 2 weeks after development of a facial rash. Brain imaging showed bilateral, symmetric signal abnormalities within the basal ganglia and subcortical white matter. Despite treatment with high-dose steroids, she continued to have difficulty speaking with evidence of jaw dystonia on examination. Jaw dystonia rapidly improved with the initiation of levodopa. Repeat evaluation 3 months later exhibited the absence of jaw dystonia and near resolution of the imaging abnormalities. Our patient demonstrated a unique presentation with jaw dystonia refractory to traditional treatment for NPSLE. Such a presentation likely represents a severe variant of NPSLE requiring both immunosuppressive and symptomatic therapies.

Entities:  

Keywords:  clinical specialty; dystonic disorders; imaging techniques; movement disorders; neuroimmunology; parkinsonian disorders

Year:  2017        PMID: 29276561      PMCID: PMC5734500          DOI: 10.1177/1941874417698323

Source DB:  PubMed          Journal:  Neurohospitalist        ISSN: 1941-8744


  33 in total

1.  Stiff person syndrome as the initial manifestation of systemic lupus erythematosus.

Authors:  Renato P Munhoz; Hudson Fameli; Hélio A G Teive
Journal:  Mov Disord       Date:  2010-03-15       Impact factor: 10.338

2.  Reversible parkinsonism in systemic lupus erythematosus.

Authors:  E K Tan; L L Chan; A P Auchus
Journal:  J Neurol Sci       Date:  2001-12-15       Impact factor: 3.181

3.  Parkinsonism as unusual neurological complication in childhood systemic lupus erythematosus.

Authors:  K L Kwong; R Chu; S N Wong
Journal:  Lupus       Date:  2000       Impact factor: 2.911

Review 4.  Neuropsychiatric manifestations in pediatric systemic lupus erythematosus: a 20-year study.

Authors:  H H Yu; J H Lee; L C Wang; Y H Yang; B L Chiang
Journal:  Lupus       Date:  2006       Impact factor: 2.911

5.  Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance.

Authors:  John G Hanly; Grace McCurdy; Lisa Fougere; Jo-Anne Douglas; Kara Thompson
Journal:  J Rheumatol       Date:  2004-11       Impact factor: 4.666

6.  Neuropsychiatric syndromes in lupus: prevalence using standardized definitions.

Authors:  R L Brey; S L Holliday; A R Saklad; M G Navarrete; D Hermosillo-Romo; C L Stallworth; C R Valdez; A Escalante; I del Rincón; G Gronseth; C B Rhine; P Padilla; D McGlasson
Journal:  Neurology       Date:  2002-04-23       Impact factor: 9.910

7.  Patients with antiphospholipid antibodies: CT and MR findings of the brain.

Authors:  J M Provenzale; D P Barboriak; N B Allen; T L Ortel
Journal:  AJR Am J Roentgenol       Date:  1996-12       Impact factor: 3.959

8.  Tremor as an early manifestation of systemic lupus erythematosus.

Authors:  E Venegoni; R Biasioli; E Lamperti; E Rinaldi; A Salmaggi; C Novi
Journal:  Clin Exp Rheumatol       Date:  1994 Mar-Apr       Impact factor: 4.473

9.  The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus.

Authors:  Wilmer L Sibbitt; John R Brandt; Courtney R Johnson; Marcos E Maldonado; Samir R Patel; Corey C Ford; Arthur D Bankhurst; William M Brooks
Journal:  J Rheumatol       Date:  2002-07       Impact factor: 4.666

10.  Association between lupus psychosis and anti-ribosomal P protein antibodies.

Authors:  E Bonfa; S J Golombek; L D Kaufman; S Skelly; H Weissbach; N Brot; K B Elkon
Journal:  N Engl J Med       Date:  1987-07-30       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.